Evidence map›Paper›PMID 36161736›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

Access to Enantiomerically Pure P-Stereogenic Primary Aminophosphine Sulfides under Reductive Conditions.

Tanja Huber, Noel Angel Espinosa-Jalapa, Jonathan O Bauer

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tanja HuberInstitut für Anorganische Chemie, Fakultät für Chemie und Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0002-5538-430X
Noel Angel Espinosa-JalapaInstitut für Anorganische Chemie, Fakultät für Chemie und Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0003-2425-2707
Jonathan O BauerInstitut für Anorganische Chemie, Fakultät für Chemie und Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0002-9575-7430
University of Regensburg · DE

Funding

Elitenetzwerk Bayern Project N-LW-NW-2016-366
6 · The paper itself

Abstract

Stereochemically pure phosphines with phosphorus-heteroatom bonds and P-centered chirality are a promising class of functional building blocks for the design of chiral ligands and organocatalysts. A route to enantiomerically pure primary aminophosphine sulfides was opened through stereospecific reductive C-N bond cleavage of phosphorus(V) precursors by lithium in liquid ammonia. The chemoselectivity of the reaction as a function of reaction time, substrate pattern, and chiral auxiliary was investigated. In the presence of exclusively aliphatic groups bound to the phosphorus atom, all competing reductive side reactions are totally prevented. The absolute configurations of all P-stereogenic compounds were determined by single-crystal X-ray diffraction analysis. Their use as synthetic building blocks was demonstrated. The lithium salt of (R)-BINOL-dithiophosphoric acid proved to be a useful stereochemical probe to determine the enantiomeric purity. Insights into the coordination mode of the lithium-based chiral complex formed in solution was provided by NMR spectroscopy and DFT calculations.

Indexed as

alkali metalscleavage reactionsphosphorusP-stereogenic compoundsstructure elucidation

Identifiers

PMID36161736
PMCPMC10092265
OpenAlexW4297260081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.